PH-797804   Click here for help

GtoPdb Ligand ID: 7818

PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: PH-797804 is a diarylpyridinone inhibitor of p38 mitogen-activated protein (MAP) kinase [3].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 59.81
Molecular weight 476.05
XLogP 5.54
No. Lipinski's rules broken 1
Click here for help
Canonical SMILES CNC(=O)c1ccc(c(c1)n1c(C)cc(c(c1=O)Br)OCc1ccc(cc1F)F)C
Isomeric SMILES CNC(=O)c1ccc(c(c1)n1c(C)cc(c(c1=O)Br)OCc1ccc(cc1F)F)C
InChI InChI=1S/C22H19BrF2N2O3/c1-12-4-5-14(21(28)26-3)9-18(12)27-13(2)8-19(20(23)22(27)29)30-11-15-6-7-16(24)10-17(15)25/h4-10H,11H2,1-3H3,(H,26,28)
No information available.
Summary of Clinical Use Click here for help
PH-797804 has completed Phase 2 clinical trials for several inflammatory conditions, including rheumatoid and osteoarthritis, chronic obstructive pulmonary disease (COPD) [2] as well as PH-797804 vs. placebo for neuropathic pain associated with post-herpetic neuralgia. Click here to link to's list of these completed trials. There are no currently active trials assessing PH-797804 (March 2016).